Pharvaris N.V. (9EN.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 03:47PM CEST. Market open.
| Previous close | 20.40 |
| Open | 20.80 |
| Bid | 20.60 x N/A |
| Ask | 22.80 x N/A |
| Day's range | 20.00 - 20.80 |
| 52-week range | 7.25 - 29.60 |
| Volume | |
| Avg. volume | 12 |
| Market cap | 1.135B |
| Beta (5Y monthly) | -3.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program
Pharvaris (PHVS) rises 6% after the FDA lifts the clinical hold on the investigational candidate, deucrictibant, for the prophylactic treatment of HAE attacks.
- Simply Wall St.
Pharvaris N.V.'s (NASDAQ:PHVS) largest shareholders are private equity firms who were rewarded as market cap surged US$578m last week
Key Insights Significant control over Pharvaris by private equity firms implies that the general public has more power...
© 2024 Yahoo. All rights reserved.